vancomycin

Aztreonam is a synthetic antibiotic that works by inhibiting cell wall synthesis, and it is naturally resistant to some β-lactamases. Aztreonam has a low incidence of toxicity, but it must be administered parenterally.

…treatment of MRSA infections with vancomycin, an antibiotic often considered as a last line of defense against MRSA, has led to the emergence of vancomycin-resistant S. aureus (VRSA), against which few agents are effective. In 2005 in the United States, deaths from MRSA (approximately 18,000) surpassed deaths from HIV/AIDS (approximately…

Treatment with vancomycin, a glycopeptide antibiotic often considered a last line of defense against MRSA, has led to the emergence of vancomycin-resistant S. aureus (VRSA), against which few agents are effective. In addition, the use of teicoplanin, an antibiotic derived from vancomycin, has given rise to teicoplanin-resistant…